|
Lincomycin 2,4-Phosphate;Clindamycin Phosphate EP Impurity G
|
林可霉素 2,4-磷酸酯；克林霉素磷酸酯 EP 雜質(zhì) G
|
|
|
Clindamycin Phosphate Impurity 1
|
克林霉素磷酸酯雜質(zhì)1
|
648910-17-2
|
|
Clindamycin HCl
|
克林霉素A鹽酸鹽
|
21462-39-5
|
|
Pioglitazone EP Impurity B
|
吡格列酮EP雜質(zhì)B
|
136401-69-9
|
|
Pioglitazone Impurity A
|
吡格列酮雜質(zhì)A
|
625853-74-9
|
|
Clindamycin Impurity 7
|
克林霉素雜質(zhì)7
|
|
|
Clindamycin Phosphate EP Impurity D
|
克林霉素磷酸酯EP雜質(zhì)D
|
54887-30-8
|
|
Clindamycin Hydrochloride EP Impurity F HCl
|
鹽酸克林霉素EP雜質(zhì)F
|
|
|
Clindamycin Sulfoxide 2-Palmitate Isomer
|
克林霉素亞砜2-棕櫚酸酯異構(gòu)體
|
|
|
Clindamycin Impurity 1
|
克林霉素雜質(zhì)1
|
16684-06-3
|
|
Clindamycin Impurity 20
|
克林霉素雜質(zhì)20
|
2090590-93-3
|
|
Clindamycin Impurity 3
|
克林霉素雜質(zhì)3
|
1440605-51-5
|
|
Clindamycin EP Impurity B
|
克林霉素EP雜質(zhì)B
|
18323-43-8
|
|
Pioglitazone Impurity F
|
吡格列酮雜質(zhì)F
|
1391052-15-5
|
|
Pioglitazone Aldehyde HCl
|
吡格列酮醛鹽酸鹽
|
856255-80-6
|
|
Pioglitazone EP Impurity E
|
吡格列酮EP雜質(zhì)E
|
868754-42-1
|
|
Pioglitazone Impurity 3
|
吡格列酮雜質(zhì)3
|
669716-56-7
|
|
Empagliflozin Impurity A
|
恩格列凈雜質(zhì)A
|
|
|
(1R)-1,5-Dihydroxy Empagliflozin
|
(1R)-1,5-二羥基恩格列凈
|
1620758-34-0
|
|
Erythromycin;Roxithromycin EP Impurity A
|
紅霉素；羅紅霉素EP雜質(zhì)A
|
114-07-8
|
|
Empagliflozin
|
恩格列凈
|
864070-44-0
|
|
Empagliflozin Sugar Dimer Impurity
|
恩格列凈糖二聚體雜質(zhì)
|
|
|
Indapamide Impurity 13
|
吲達帕胺雜質(zhì)13
|
70049-77-3
|
|
Roxithromycin Impurity I
|
羅紅霉素雜質(zhì)I
|
425365-66-8
|
|
Empagliflozin Sugar Dimer Impurity 1
|
恩格列凈糖二聚體雜質(zhì)1
|
|
|
5-Hydroxy Indapamide
|
5-羥基吲達帕胺
|
126750-70-7
|
|
Empagliflozin Impurity 7
|
恩格列凈雜質(zhì)7
|
915095-89-5
|
|
Indapamide Impurity 11
|
吲達帕胺雜質(zhì)11
|
1856658-28-0
|
|
Indapamide EP Impurity A
|
吲達帕胺EP雜質(zhì)A
|
85440-79-5
|
|
Indapamide EP Impurity C
|
吲達帕胺EP雜質(zhì)C
|
77083-51-3
|
|
Empagliflozin Impurity B
|
恩格列凈雜質(zhì)B
|
|
|
Indapamide Impurity 12
|
吲達帕胺雜質(zhì)12
|
1205-30-7
|
|
Roxithromycin
|
羅紅霉素
|
80214-83-1
|
|
Indapamide Impurity B
|
吲達帕胺雜質(zhì)B
|
31529-47-2
|
|
Indapamide EP Impurity B
|
吲達帕胺EP雜質(zhì)B
|
63968-75-2
|
|
Empagliflozin Impurity D
|
恩格列凈雜質(zhì)D
|
|
|
Empagliflozin Impurity 8
|
恩格列凈雜質(zhì)8
|
|
|
Indapamide Impurity 1
|
吲達帕胺雜質(zhì)1
|
|
|
Empagliflozin Impurity 2
|
恩格列凈雜質(zhì)2
|
|
|
Empagliflozin Impurity 9
|
恩格列凈雜質(zhì)9
|
1360568-68-8
|
|
Indapamide Glucuronide
|
吲達帕胺葡糖苷酸
|
|
|
Pioglitazone HCl
|
鹽酸吡格列酮
|
112529-15-4
|
|
Pioglitazone Metabolite M1
|
吡格列酮代謝物 M1
|
74772-78-4
|
|
Clindamycin Phosphate EP Impurity F
|
克林霉素磷酸酯EP雜質(zhì)F
|
27480-30-4
|
|
Clindamycin B 3-phosphate
|
克林霉素 B 3-磷酸鹽
|
|
|
Pioglitazone EP Impurity D
|
吡格列酮EP雜質(zhì)D
|
868754-41-0
|
|
Pioglitazone EP Impurity C
|
吡格列酮EP雜質(zhì)C
|
952188-00-0
|
|
Empagliflozin Impurity 25
|
恩格列凈雜質(zhì)25
|
86087-24-3
|
|
Indapamide
|
吲達帕胺
|
26807-65-8
|
|
Roxithromycin N-Oxide
|
羅紅霉素N-氧化物
|
1460313-73-8
|
|
Roxithromycin Impurity K
|
羅紅霉素雜質(zhì)K
|
|
|
Roxithromycin EP Impurity J HCl
|
羅紅霉素EP雜質(zhì)J鹽酸鹽
|
134834-12-1
|
|
Roxithromycin Impurity H
|
羅紅霉素雜質(zhì)H
|
|
|
Roxithromycin Impurity E
|
羅紅霉素雜質(zhì)E
|
|
|
Roxithromycin EP Impurity D
|
羅紅霉素EP雜質(zhì)D
|
134931-00-3
|
|
Roxithromycin EP Impurity C
|
羅紅霉素EP雜質(zhì)C
|
111321-02-9
|
|
Roxithromycin EP Impurity B
|
羅紅霉素EP雜質(zhì)B
|
214902-82-6
|
|
Roxithromycin EP Impurity F
|
羅紅霉素EP雜質(zhì)F
|
118267-18-8
|
|
Roxithromycin Impurity G
|
羅紅霉素雜質(zhì)G
|
425365-64-6
|
|
Valproic Acid EP Impurity C
|
丙戊酸EP雜質(zhì)C
|
62391-99-5
|
|
Valproic Acid EP Impurity J
|
丙戊酸EP雜質(zhì)J
|
5340-48-7
|
|
Valproic Acid EP Impurity D
|
丙戊酸EP雜質(zhì)D
|
52061-75-3
|
|
Valproic Acid EP Impurity G
|
丙戊酸EP雜質(zhì)G
|
52061-73-1
|
|
Valproic Acid
|
丙戊酸
|
99-66-1
|
|
Valproic Acid Impurity 9
|
丙戊酸雜質(zhì)9
|
|
|
Valproic Acid Related Compound A
|
丙戊酸相關(guān)化合物A
|
99-67-2
|
|
Valproic Acid EP Impurity L
|
丙戊酸EP雜質(zhì)L
|
97-61-0
|
|
Valproic Acid EP Impurity B
|
丙戊酸EP雜質(zhì)B
|
20225-24-5
|
|
Indacaterol Impurity 6 HCl
|
茚達特羅雜質(zhì)6鹽酸鹽
|
312753-53-0
|
|
Tofacitinib Impurity F
|
托法替尼雜質(zhì) F
|
384338-23-2
|
|
Tofacitinib Impurity 42
|
托法替尼雜質(zhì) 42
|
1092578-46-5
|
|
Indacaterol Impurity 2
|
茚達特羅雜質(zhì)2
|
1026461-20-0
|
|
Tofacitinib Impurity N
|
托法替尼雜質(zhì) N
|
1260614-73-0
|
|
Tofacitinib Impurity L
|
托法替尼雜質(zhì) L
|
1675248-19-7
|
|
Indacaterol Impurity 5
|
茚達特羅雜質(zhì)5
|
173140-90-4
|
|
Tofacitinib Citrate
|
托法替尼枸櫞酸鹽
|
540737-29-9
|
|
Indacaterol Impurity 1
|
茚達特羅雜質(zhì)1
|
1403389-05-8
|
|
Tofacitinib Impurity 24
|
托法替尼雜質(zhì) 24
|
1092578-48-7
|
|
Tofacitinib Impurity I
|
托法替尼雜質(zhì) I
|
|
|
Tofacitinib Impurity 10
|
托法替尼雜質(zhì) 10
|
477600-74-1
|
|
Indacaterol Impurity 7
|
茚達特羅雜質(zhì)7
|
435273-75-9
|
|
Indacaterol Maleate
|
馬來酸茚達特羅
|
753498-25-8
|
|
Tofacitinib Impurity C Citrate
|
托法替尼雜質(zhì) C 檸檬酸鹽
|
1092578-47-6
|
|
Tofacitinib Impurity J
|
托法替尼雜質(zhì) J
|
|
|
(S)-Indacaterol
|
(S)-茚達特羅
|
1235445-80-3
|
|
Valproic Acid EP Impurity I
|
丙戊酸EP雜質(zhì)L
|
13310-75-3
|
|
Tofacitinib Impurity Q
|
托法替尼雜質(zhì) Q
|
3680-69-1
|
|
Tofacitinib Impurity T
|
托法替尼雜質(zhì) T
|
1092578-43-2
|
|
Tofacitinib Impurity 39
|
托法替尼雜質(zhì) 39
|
923036-30-0
|
|
Tofacitinib Impurity V
|
托法替尼雜質(zhì) V
|
|
|
Tofacitinib Impurity U
|
托法替尼雜質(zhì) U
|
1616760-97-4
|
|
Tofacitinib Impurity 9
|
托法替尼雜質(zhì) 9
|
477600-73-0
|
|
Tofacitinib Impurity R
|
托法替尼雜質(zhì) R
|
479633-63-1
|
|
Tofacitinib Impurity P
|
托法替尼雜質(zhì) P
|
1252883-90-1
|
|
Valproic Acid Related Compound A Sodium Salt
|
丙戊酸相關(guān)化合物A鈉鹽
|
76944-37-1
|
|
Valproic Acid related compound B
|
丙戊酸相關(guān)化合物B
|
|
|
Valproic Acid EP Impurity K
|
丙戊酸EP雜質(zhì)K
|
5343-52-2
|
|
Valproic Acid Impurity F
|
丙戊酸雜質(zhì)F
|
|
|
5-Hydroxy Valproic Acid Sodium Salt
|
5-羥基丙戊酸鈉鹽
|
78644-53-8
|
|
Valproic Acid Impurity 10
|
丙戊酸雜質(zhì)10
|
109578-13-4
|